• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在实验性血栓形成中,组织型纤溶酶原激活剂脉冲喷雾溶栓期间经血栓内给予前列腺素E1的效果。

Effects of intrathrombic administration of prostaglandin E1 during pulse-spray thrombolysis with tissue-type plasminogen activator in experimental thrombosis.

作者信息

Valji K, Bookstein J J

机构信息

Department of Radiology, University of California, San Diego 92103.

出版信息

Radiology. 1993 Mar;186(3):873-6. doi: 10.1148/radiology.186.3.8430201.

DOI:10.1148/radiology.186.3.8430201
PMID:8430201
Abstract

The effects of intrathrombic and intravenous injection of prostaglandin E1 (PGE1) during pulse-spray thrombolysis were studied in a rabbit model. Thrombi were produced in the inferior vena cava of 46 rabbits by means of vessel wall injury and placement of steel coils. At 2 days, pulse-spray thrombolysis was performed by using a catheter with multiple side holes spanning the clot. A control group received injections of saline. In all other rabbits, 3 mg of tissue-type plasminogen activator (tPA) was injected into the thrombus over 1 hour, and 500 U of heparin was intravenously administered. PGE1 was administered either intravenously (50 micrograms) or directly into the thrombus (10, 25, or 50 micrograms) in four groups. After treatment, the rabbits were killed and the residual clot was weighed. The relationship between clot length and volume measured on angiograms and clot weight was assessed in 13 additional untreated rabbits. Linear regression analysis was used to estimate the initial clot weight on the basis of measured clot length in treated animals. The extent of clot lysis was significantly greater with injection of tPA and 10-, 25-, or 50-micrograms PGE1 directly into the thrombous than with administration of tPA alone.

摘要

在兔模型中研究了脉冲喷射溶栓期间经血栓内和静脉注射前列腺素E1(PGE1)的效果。通过血管壁损伤和放置钢圈在46只兔的下腔静脉中形成血栓。在第2天,使用带有多个横跨血栓侧孔的导管进行脉冲喷射溶栓。对照组注射生理盐水。在所有其他兔中,在1小时内将3mg组织型纤溶酶原激活剂(tPA)注入血栓,并静脉给予500U肝素。四组兔分别经静脉给予PGE1(50μg)或直接注入血栓(10、25或50μg)。治疗后,处死兔并对残余血栓称重。在另外13只未经治疗的兔中评估血管造影测量的血栓长度和体积与血栓重量之间的关系。使用线性回归分析根据治疗动物中测量的血栓长度估计初始血栓重量。与单独给予tPA相比,将tPA与10、25或50μg PGE1直接注入血栓时,血栓溶解程度明显更大。

相似文献

1
Effects of intrathrombic administration of prostaglandin E1 during pulse-spray thrombolysis with tissue-type plasminogen activator in experimental thrombosis.在实验性血栓形成中,组织型纤溶酶原激活剂脉冲喷雾溶栓期间经血栓内给予前列腺素E1的效果。
Radiology. 1993 Mar;186(3):873-6. doi: 10.1148/radiology.186.3.8430201.
2
Efficacy of adjunctive intrathrombic heparin with pulse spray thrombolysis in rabbit inferior vena cava thrombosis.兔下腔静脉血栓形成时经皮腔内脉冲喷射溶栓联合腔内注射肝素的疗效
Invest Radiol. 1992 Nov;27(11):912-7. doi: 10.1097/00004424-199211000-00007.
3
Use of a direct thrombin inhibitor (argatroban) during pulse-spray thrombolysis in experimental thrombosis.
J Vasc Interv Radiol. 1995 Jan-Feb;6(1):91-5. doi: 10.1016/s1051-0443(95)71067-3.
4
Pulse-spray pharmacomechanical thrombolysis of thrombosed hemodialysis access grafts: long-term experience and comparison of original and current techniques.脉冲喷雾药物机械溶栓治疗血栓形成的血液透析通路移植物:长期经验及原始技术与当前技术的比较
AJR Am J Roentgenol. 1995 Jun;164(6):1495-500; discussion 1501-3. doi: 10.2214/ajr.164.6.7754901.
5
Augmented experimental pulse-spray thrombolysis with tissue plasminogen activator, enabling dose reduction by one or more orders of magnitude.使用组织纤溶酶原激活剂增强实验性脉冲喷雾溶栓,可使剂量降低一个或多个数量级。
J Vasc Interv Radiol. 2000 Mar;11(3):299-303. doi: 10.1016/s1051-0443(07)61421-3.
6
Augmented pulse-spray thrombolysis with tPA by early pulsed intrathrombic plasminogen enrichment.通过早期脉冲式血栓内纤溶酶原富集实现tPA增强脉冲喷雾溶栓。
J Vasc Interv Radiol. 1998 Jul-Aug;9(4):618-25. doi: 10.1016/s1051-0443(98)70332-x.
7
Plasminogen-enriched pulse-spray thrombolysis with tPA: further developments.使用组织型纤溶酶原激活剂(tPA)的富含纤溶酶原脉冲喷雾溶栓:进一步进展。
J Vasc Interv Radiol. 2000 Nov-Dec;11(10):1353-62. doi: 10.1016/s1051-0443(07)61316-5.
8
Pulse-spray thrombolysis with reteplase: optimization and comparison with tPA in a rabbit model.瑞替普酶脉冲喷雾溶栓:在兔模型中的优化及与组织型纤溶酶原激活剂的比较
J Vasc Interv Radiol. 2001 Nov;12(11):1319-24. doi: 10.1016/s1051-0443(07)61558-9.
9
Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).大剂量组织型纤溶酶原激活剂及血浆半衰期延长的杂交纤溶酶原激活剂(K2tu-PA:CGP 42935)的溶栓和出血作用
Thromb Haemost. 1993 Aug 2;70(2):294-300.
10
Cerebral venous congestion as indication for thrombolytic treatment.脑静脉淤血作为溶栓治疗的指征。
Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):675-87. doi: 10.1007/s00270-007-9046-1.